Menu UF Health Home Menu

Content Tagged Mark Atkinson Subscribe to RSS Feed


Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes

Published: Nov 21st, 2015

UFDI and nPOD investigators found that the presence of β-cells as well as insulitis several years after T1D diagnosis in children and young adults suggest that the chronicity of islet […]


Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice

Published: Nov 20th, 2015

UFDI researchers Amanda Posgai, Ph.D. and Mark Atkinson, Ph.D. and collaborators examine a new approach for preserving beta cell function in patients with recent onset T1D.


Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

Published: Nov 12th, 2015

UFDI Researcher Mark Atkinson, Ph.D. and collaborators found that that GABA is rapidly absorbed and tolerated in human beings, and its endocrine effects suggest potential therapeutic benefits for diabetes.


Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β

Published: Nov 9th, 2015

Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes than the general population (18-30 vs. 1.2-6.3%), independent of body mass index and antipsychotic medication, suggesting […]


Do you have extra diabetes supplies you no longer need?

Published: Oct 20th, 2015

UFDI Director Mark Atkinson, Ph.D. and Insulin for Life found a way to recycle unused diabetes supplies.


Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

Published: Oct 18th, 2015

UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]


Immunoproteomic Profiling of Anti-Viral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays

Published: Oct 12th, 2015

UFDI investigators and collaborators at Arizona State University found that the Epstein-Barr virus may have a role in type 1 diabetes development.


UFDI researchers work to develop type 1 diabetes vaccine

Published: Sep 15th, 2015

Two recent publications explored different methods of delivering a vaccine for type 1 diabetes, both of which prevented 40 percent of mice from developing the disease.


UF researchers release publication on the influence of type 1 diabetes on pancreatic weight

Published: Sep 13th, 2015

UFDI faculty and a University of Miami researcher found that “reduced pancreas weight allows for comparisons across a wide range of donor ages by eliminating confounding variables.”


Network for Pancreatic Organ Donors update via JDRF

Published: Sep 11th, 2015

“In less than a decade, nPOD has provided more than 140 research teams with tissues for T1D-related research and grown from 6 collaborating labs to 168 in 17 countries.”